To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Actis in $48m India healthcare deal
The private equity firm has acquired a ‘significant stake' in Indian pharmaceutical company Symbiotec as it raises its third emerging markets fund.
